BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35498541)

  • 21. LncRNA AWPPH promotes the proliferation, migration and invasion of ovarian carcinoma cells via activation of the Wnt/β‑catenin signaling pathway.
    Yu G; Wang W; Deng J; Dong S
    Mol Med Rep; 2019 May; 19(5):3615-3621. PubMed ID: 30896797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRIM44 facilitates ovarian cancer proliferation, migration, and invasion by inhibiting FRK.
    Yu XZ; Yuan JL; Ye H; Yi K; Qie MR; Hou MM
    Neoplasma; 2021 Jul; 68(4):751-759. PubMed ID: 34034495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma.
    Chen H; Liu J; Wang H; Cheng Q; Zhou C; Chen X; Ye F
    J Cancer; 2019; 10(6):1580-1592. PubMed ID: 31031868
    [No Abstract]   [Full Text] [Related]  

  • 24. Low Expression of Protocadherin-8 Promotes the Progression of Ovarian Cancer.
    Cao Y; Yu Y; Chen X; Ren F; Zhang R; Jia Y; Ren Z; Sun R; Li J; Shi H
    Int J Gynecol Cancer; 2018 Feb; 28(2):346-354. PubMed ID: 29324532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long Non-coding RNA
    Chen J; Li X; Yang L; Zhang J
    Front Cell Dev Biol; 2020; 8():625730. PubMed ID: 33614632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y; Lv M; Fang Y; Lu J; Wu Y
    J Ovarian Res; 2021 Nov; 14(1):161. PubMed ID: 34789303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non‑coding RNA BANCR promotes proliferation, invasion and migration in esophageal squamous cell carcinoma cells via the Raf/MEK/ERK signaling pathway.
    Yu X; Huang M; Yang G
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-96-5p promotes the proliferation and migration of ovarian cancer cells by suppressing Caveolae1.
    Liu B; Zhang J; Yang D
    J Ovarian Res; 2019 Jun; 12(1):57. PubMed ID: 31228941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis.
    Li Q; Yu D; Yu Z; Gao Q; Chen R; Zhou L; Wang R; Li Y; Qian Y; Zhao J; Rosell R; Tao M; Xie Y; Xu C
    Transl Lung Cancer Res; 2021 Feb; 10(2):936-954. PubMed ID: 33718034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA TUG1 facilitates cell ovarian cancer progression through targeting MiR-29b-3p/MDM2 axis.
    Yang X; Xin N; Qu HJ; Wei L; Han Z
    Anat Rec (Hoboken); 2020 Dec; 303(12):3024-3034. PubMed ID: 31930662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exogenous interleukin-1 beta promotes the proliferation and migration of HeLa cells via the MEK/ERK signaling pathway.
    Zhang J; Wang L; Liu Y; Liu W; Ma Z
    Mol Biol Rep; 2022 May; 49(5):3765-3772. PubMed ID: 35301650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Receptor interacting protein kinase 4 promotes cell proliferation, migration, and invasion in ovarian cancer via targeting protein kinase C delta.
    Jin A; Zhang L; Fang G; Chen Y
    Drug Dev Res; 2022 Apr; 83(2):407-415. PubMed ID: 34414590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance.
    Liu T; Jin ZW; Li Y; Zhang G; Yang XY; Xu XM; Ma YC
    J Cancer Res Ther; 2022 Apr; 18(2):488-495. PubMed ID: 35645119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Overexpression of Keratin 23 Promotes Migration of Ovarian Cancer via Epithelial-Mesenchymal Transition.
    Ren M; Gao Y; Chen Q; Zhao H; Zhao X; Yue W
    Biomed Res Int; 2020; 2020():8218735. PubMed ID: 33204716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-508 suppresses epithelial-mesenchymal transition, migration, and invasion of ovarian cancer cells through the MAPK1/ERK signaling pathway.
    Hong L; Wang Y; Chen W; Yang S
    J Cell Biochem; 2018 Sep; 119(9):7431-7440. PubMed ID: 29781537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Significance and Related Mechanisms of Hexokinase 1 in Ovarian Cancer.
    Li Y; Tian H; Luo H; Fu J; Jiao Y; Li Y
    Onco Targets Ther; 2020; 13():11583-11594. PubMed ID: 33204111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circular RNA Foxo3 enhances progression of ovarian carcinoma cells.
    Wang L; Chen J; Lu C
    Aging (Albany NY); 2021 Sep; 13(18):22432-22443. PubMed ID: 34555810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TBC1D2 Promotes Ovarian Cancer Metastasis
    Tian J; Liang X; Wang D; Tian J; Liang H; Lei T; Yan Z; Wu D; Liu X; Liu S; Yang Y
    Front Oncol; 2022; 12():766077. PubMed ID: 35574392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-18a suppresses ovarian carcinoma progression by targeting CBX7 and regulating ERK/MAPK signaling pathway and epithelial-to-mesenchymal transition.
    Zhao Y; Liu XL; Huang JH; Yin AJ; Zhang H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5292-5302. PubMed ID: 32495862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USP10 promotes proliferation and migration and inhibits apoptosis of endometrial stromal cells in endometriosis through activating the Raf-1/MEK/ERK pathway.
    Chen Q; Hang Y; Zhang T; Tan L; Li S; Jin Y
    Am J Physiol Cell Physiol; 2018 Dec; 315(6):C863-C872. PubMed ID: 30281322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.